Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Omics Prediction of Radiation Pneumonitis Risk in Lung Cancer Patients After Immunotherapy and Thoracic Radiotherapy

NCT07742800 is registered in ClinicalTrials.gov with HAN GUANG as lead sponsor.

NCT NCT07742800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07742800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Omics Prediction of Radiation Pneumonitis Risk in Lung Cancer Patients After Immunotherapy and Thoracic Radiotherapy
Lead sponsor
HAN GUANG
Phase
Observational
Overall status
Not yet recruiting
Start date
August 15, 2026
Completion date
August 15, 2028
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer (nsclc), lung cancer (sclc)